恶性心包积液的内科治疗进展

©1994-2010ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.(BRM)bleomycinthermotherapyOncolProg,2007,5(4),10%15%1,21%2,3,1/23,1/32,,,,,1030ml4,,,,,,,©1994-2010ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.(2000),:(1)(CR):,,30;(2)(PR):50%,,30;(3)(NC):,;+/100%,,:12060mg400mg50ml5%,,,7217%100%5-,,,5,2,-30500U510kE10mg4mg,,,8213%100%,-2,,,,Uhi6Toh7,3-2,2576%8;309313%,9,19-294%102596%,88%11349411%,12,4,,,DNA,DNA,S,[1316],3060mg,8715%96%,,5414330,,,[17][18],©1994-2010ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.[20]281500U500U,9219%,217,,,,,76%100%,,,,1.BrigdenML.Hematologicandoncologicemergencises.Do2ingthemostgoodintheleasttime.PostgradMed,2001,1091432.ShepherdFA.Malignantpericardialeffusion.CurrOpinOn2col,1997,9(2)1703.DeCampMMJr,MentzerSJ,SwansonSJ,etal.Malignanteffusivediseaseofthepleuraandpericardium.Chest,1997,112(4)291S4.WarrenWH.Malignanciesinvolvingthepericardium.SeminThoracCardiovascSurg,2000,12(2)1195.,,.17.,2001,(21)6.UhiToh,TeruhikoFujii,NaokoSeki,etal.Characteriza2tionofIL-2-activatedTILsandtheiruseinintrapericardialimmunotherapyinmalignantpericardialeffusion.CancerIm2munolImmunother,2006,5512197.TohU,FujiiT,SekiN,etal.Intrapericardialcellularim2munotherapyformalignantpericardialeffusionusingautolo2gousIL-2-activatedTILs.JClinOncol,2006,24(18S)(Suppl)25558.,,,.-225.,2001,17(11)8959.,,,.-2.,2006,14(6)69910..17.,2003,16(1)5111.,,,.DDP+-25.,2002,14(2)13212.,..,2005,9(11)98513.,,,..,2003,10(4)34414..9.,2005,9(12)108315.,,.23.,1999,26(5)33216.CantoA,GuijarroR,AmauA,etal.Thoracoscopicperi2cardialfenestration:Diagnosticandtherapeuticaspects.Thorax,1993,48(11)117817..11.,2003,10(3)21318.,..,2005,12(1)3219.,,..,2001,(5)35320.,,,..,1998,21(7)40621.,,,.28.,2006,15(1)68